Peter Jähnig

1.1k total citations
12 papers, 428 citations indexed

About

Peter Jähnig is a scholar working on Cognitive Neuroscience, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Peter Jähnig has authored 12 papers receiving a total of 428 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cognitive Neuroscience, 4 papers in Cellular and Molecular Neuroscience and 2 papers in Neurology. Recurrent topics in Peter Jähnig's work include EEG and Brain-Computer Interfaces (6 papers), Sleep and Wakefulness Research (5 papers) and Neuroscience and Neuropharmacology Research (3 papers). Peter Jähnig is often cited by papers focused on EEG and Brain-Computer Interfaces (6 papers), Sleep and Wakefulness Research (5 papers) and Neuroscience and Neuropharmacology Research (3 papers). Peter Jähnig collaborates with scholars based in United Kingdom, Germany and France. Peter Jähnig's co-authors include Marc Jobert, Hartmut Schulz, Klaus W. Lange, Peter Jenner, C. D. Marsden, H. Wachtel, L. Turski, P.-A. Löschmann, T. Honoré and Peter‐A. Löschmann and has published in prestigious journals such as Journal of Clinical Oncology, SLEEP and Psychopharmacology.

In The Last Decade

Peter Jähnig

12 papers receiving 414 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Jähnig United Kingdom 9 239 186 134 97 40 12 428
Jasna Šaponjić Serbia 15 365 1.5× 236 1.3× 77 0.6× 38 0.4× 169 4.2× 50 526
Raija Soikkeli Finland 7 222 0.9× 129 0.7× 184 1.4× 11 0.1× 10 0.3× 8 399
Christian Richard United States 8 264 1.1× 114 0.6× 35 0.3× 25 0.3× 31 0.8× 13 427
Benoît Crépon France 8 489 2.0× 272 1.5× 42 0.3× 29 0.3× 19 0.5× 12 579
Kim T. E. Olde Dubbelink Netherlands 10 567 2.4× 103 0.6× 404 3.0× 37 0.4× 6 0.1× 11 741
Veronika Majerová Czechia 10 93 0.4× 56 0.3× 168 1.3× 117 1.2× 31 0.8× 18 518
Michael Waszak United States 10 222 0.9× 181 1.0× 29 0.2× 36 0.4× 18 0.5× 12 359
Xuenan Wang China 10 112 0.5× 95 0.5× 134 1.0× 28 0.3× 27 0.7× 27 307
Benjamin Pittman-Polletta United States 11 222 0.9× 108 0.6× 18 0.1× 30 0.3× 61 1.5× 15 362
Roxana A. Stefanescu United States 13 383 1.6× 162 0.9× 24 0.2× 44 0.5× 9 0.2× 14 502

Countries citing papers authored by Peter Jähnig

Since Specialization
Citations

This map shows the geographic impact of Peter Jähnig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Jähnig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Jähnig more than expected).

Fields of papers citing papers by Peter Jähnig

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Jähnig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Jähnig. The network helps show where Peter Jähnig may publish in the future.

Co-authorship network of co-authors of Peter Jähnig

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Jähnig. A scholar is included among the top collaborators of Peter Jähnig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Jähnig. Peter Jähnig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Ohlmann, Carsten‐Henning, Eva Hellmis, H. Suttmann, et al.. (2019). Abiraterone acetate plus prednisone (AA+P) without continuing LHRH-therapy in patients with metastatic chemotherapy: Naive castrations-resistant prostate cancer—Results from the SPARE-trial (NCT02077634).. Journal of Clinical Oncology. 37(15_suppl). 5046–5046. 2 indexed citations
2.
Jobert, Marc, Peter Jähnig, & Hartmut Schulz. (1999). Effect of Two Antidepressant Drugs on REM Sleep and EMG Activity during Sleep. Neuropsychobiology. 39(2). 101–109. 18 indexed citations
3.
Jobert, Marc, et al.. (1995). ECG Activity in the Sleep of Insomniac Patients under the Influence of Lormetazepam and Zopiclone. Neuropsychobiology. 31(4). 204–209. 14 indexed citations
4.
Jobert, Marc, Hartmut Schulz, & Peter Jähnig. (1995). On the Choice of Recording Duration in Pharmaco-EEG Studies. Neuropsychobiology. 32(2). 106–114. 8 indexed citations
5.
Jähnig, Peter & Marc Jobert. (1995). Methodological Considerations for the Evaluation of EEG Mapping Data: A Practical Example Based on a Placebo/Diazepam Crossover Trial. Neuropsychobiology. 31(1). 31–46. 9 indexed citations
6.
Jobert, Marc, et al.. (1994). A Computerized Method for Detecting Episodes of Wakefulness During Sleep Based on the Alpha Slow-Wave Index (ASI). SLEEP. 17(1). 37–46. 42 indexed citations
8.
Lange, Klaus W., Peter‐A. Löschmann, H. Wachtel, et al.. (1992). Terguride stimulates locomotor activity at 2 months but not 10 months after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment of common marmosets. European Journal of Pharmacology. 212(2-3). 247–252. 13 indexed citations
9.
10.
Jobert, Marc, et al.. (1992). Topographical Analysis of Sleep Spindle Activity. Neuropsychobiology. 26(4). 210–217. 125 indexed citations
11.
Löschmann, Peter‐A., Lance A. Smith, Klaus W. Lange, et al.. (1992). Motor activity following the administration of selective D-1 and D-2 dopaminergic drugs to MPTP-treated common marmosets. Psychopharmacology. 109(1-2). 49–56. 43 indexed citations
12.
Löschmann, P.-A., Klaus W. Lange, Peter Jähnig, et al.. (1991). Synergism of the AMPA-antagonist NBQX and the NMDA-antagonist CPP with L-Dopa in models of Parkinson's disease. Journal of Neural Transmission - Parkinsons Disease and Dementia Section. 3(3). 203–213. 123 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026